ArticleContemporary clinical trials communications2020

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.

Björn C Frye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.